EMA is launching a new open procurement procedure for pre- and post- authorisation studies to support regulatory decisions on human and veterinary medicines. The studies, categorised by Lots, will cover a broad range of research areas: translational (Lot 1), veterinary (Lot 2), methodological/statistical (Lot 3), qualitative (Lot 4), and pharmacoepidemiological (non-interventional) (Lot 5), as well as topics on innovative technologies for manufacturing and quality control of medicines (Lot 6), and computational methods for comparison of molecular structural features (Lot 7). The European Centre for Disease Prevention and Control (ECDC) is participating, and will have the opportunity to commission pharmacoepidemiological/real-world data (RWD) studies in Lot 5, under EMA’s coordination.
Related information: EU Funding & Tenders Portal | Procurement | European Medicines Agency (EMA) | LinkedIn
Details
- Publication date
- 10 February 2025
- Author
- European Medicines Agency